Podcasts

 

 

Physical Activity During and After Cancer Treatment, with Kristen Leung and Rachel Dudasik

 

 Hem Investigators 2017 | Interview with Jonathan W Friedberg, MD, MMSc

 Hem Investigators 2017 | Interview with S Vincent Rajkumar, MD

 MPNUpdate117 | Interview with Professor Claire N Harrison, MD

 MPNUpdate117 | Interview with Srdan Verstovsek, MD, PhD

 Lymphoma CLL Update 1 2017 | Interview with Stephen Maxted Ansell, MD, PhD

 Lymphoma CLL Update 1 2017 | Interview with Ann S LaCasce, MD, MMSc

 MDSU1 2017 | Interview with Mikkael A Sekeres, MD, MS

 MDSU1 2017 | Interview with Steven D Gore, MD

 MMTT1 2017 | Current Clinical Algorithms and Recent Therapeutic Advances in the Management of Multiple Myeloma and Related Blood Disorders

 Beyond the Guidelines 16 | Interview with Morie A Gertz, MD, MACP

 Beyond the Guidelines 16 | Interview with Julie M Vose, MD, MBA

 HOU3 2016 | Interview with Laurie H Sehn, MD, MPH

 HOU3 2016 | Interview with Sagar Lonial, MD

 HOU3 2016 | Interview with Raoul Tibes, MD, PhD

 HOU3 2016 | Interview with Loretta J Nastoupil, MD

 MTP AML 2017 | Meet The Professors: A Case-Based Discussion on the Management of Acute Myeloid Leukemia

________________________________________________

 LCU1 2017 | Interview with D Ross Camidge, MD, PhD

 LCU1 2017 | Interview with Heather Wakelee, MD

 Morbidity and Mortality 2017 Lung | A Roundtable Discussion Featuring Heather Wakelee, MD, Maria Picton, MD and Estelamari Rodriguez, MD, MPH

 LCU3 2016 | Interview with Tony SK Mok, MD

 LCU3 2016 | Interview with George R Blumenschein Jr, MD

 LCU2 2016 | Interview with Roy S Herbst, MD, PhD

 LCU2 2016 | Interview with Alice Shaw, MD, PhD

 LCU1 2016 | Interview with Bruce E Johnson, MD

 LCU1 2016 | Interview with Thomas E Stinchcombe, MD

________________________________________________

Colorectal Cancer Therapy Gets a Tune-up: ESMO 2017

New Data Provide Even More Support for Exercise During Cancer

PIVOT: Latest Data on Surveillance Versus Surgery for Prostate Cancer

Ethical Malpractice in American Clinical Oncology

Pembrolizumab, Larotrectinib Point to Future of Precision Medicine

New Data Address Critical Surgical Questions in Ovarian Cancer

Potential ASCO Practice-Changers in HER2+ Breast Cancer

Cultivating Resiliency and Combating Burnout in Oncology

A New Standard for Low-Grade Serous Cancer of the Ovary?

New ASCO Guideline for NSCLC: ‘Precision Medicine at Its Best’

New CDK4/6i Data Move Metastatic Breast Cancer Field Forward

Will pCR and Pembro Redefine Breast Cancer Treatment?

Good IDEA: Drop Adjuvant Chemo From 6 to 3 Months in CRC

Top Melanoma Studies to Be Presented at ASCO